Concepedia

Thomas Baumruker

TB

61

Publications

6K

Citations

38

H-Index

1983

Active since

Affiliations

Novartis (Austria)(Current)

Novartis (Switzerland)

Medical University of Vienna

University of Vienna

Sanden (Japan)

Thomas Baumruker is an author at Novartis (Austria) specializing in medicine, cell biology, and cell signaling.

Top concepts

Publications per year

1983–2015

61

Publications

61

The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors

Volker Brinkmann, Michael D. Davis, Christopher E. Heise et al. · Journal of Biological Chemistry · 2002 · 1.5K citations · Full text

, , +16

Phosphorylation of the Immunomodulatory Drug FTY720 by Sphingosine Kinases

Andreas Billich, Frédéric Bornancin, Piroska Dévay et al. · Journal of Biological Chemistry · 2003 · 431 citations · Full text

Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720

Barbara Zemann, Bernd Kinzel, Mathias Müller et al. · Blood · 2005 · 262 citations · Full text

A 100-kD HeLa cell octamer binding protein (OBP100) interacts differently with two separate octamer-related sequences within the SV40 enhancer.

Richard A. Sturm, Thomas Baumruker, B. Robert Franza et al. · Genes & Development · 1987 · 244 citations · Full text

Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule

Watchara Kasinrerk, Edda Fiebiger, Irena Štefanová et al. · The Journal of Immunology · 1992 · 241 citations

Rows per page

1–5 of 61